Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000892917-14-000013
Filing Date
2014-06-02
Accepted
2014-06-02 18:23:41
Documents
1
Period of Report
2014-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3761
  Complete submission text file 0000892917-14-000013.txt   5178
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 971-204-0382
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address MAGNETKAMERAN MR AB, SKEPPSBRON 28 STOCKHOLM V7 S-111 30
Business Address
Nobel Michael (Reporting) CIK: 0001307543 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 14885481